Docetaxel Injection Concentrate

Get a Price/Quote

Docetaxel Injection Concentrate Specification

Viscosity
Low viscosity

Boiling point
(Liquid product)

Melting Point
(Liquid product)

Molecular Formula
C43H53NO14

Molecular Weight
861.9 g/mol (for Docetaxel)

HS Code
30049099

EINECS No
601-698-4

Storage
Store in a refrigerator (2-8C) protected from light

Particle Size
(Liquid product)

Ph Level
4.6 to 5.3

Heavy Metal (%)
<10 ppm

Assay
99%

Other Names
Taxotere Injection Docetaxel Concentrate

CAS No
114977-28-5

Type
Pharmaceutical

Grade
Medical Grade

Usage
Cancer treatment (chemotherapy)

Purity
99%

Appearance
Clear to pale yellow solution

Application
Breast cancer lung cancer prostate cancer therapy

Raw Material
Docetaxel

Smell
Odorless

Color
Pale yellow

Form
Liquid

About Docetaxel Injection Concentrate

Jump on the opportunity to access elite cancer therapies with Docetaxel Injection Concentrate, also recognized as Taxotere Injection Docetaxel Concentrate. This medical grade, odorless pharmaceutical offers a reduced-risk approach to treating breast, lung, and prostate cancers. Boasting a ravishing purity of 99% and a low heavy metal content (<10 ppm), its clear to pale yellow solution is manufactured using select raw materials in India. With a low viscosity, this liquid formulation is stored at 2-8C, ensuring product stability. Terrific for advanced cancer treatment protocols, it aligns with stringent export standards.

Specific Uses and Application

Docetaxel Injection Concentrate is expertly crafted for use as a chemotherapy agent in cancer therapy. This solution's primary usage covers elite cancer types such as breast, lung, and prostate cancers. Designed for pharmaceutical use, it is directly administered, ensuring targeted treatment at the cellular level. Its surface of application is intravenous, allowing for rapid systemic distribution. With select components and reduced impurities, it is suitable for medical facilities prioritizing ravishing quality healthcare outcomes.

Delivery, Exchange, and Packaging Details

Estimate prompt delivery of Docetaxel Injection Concentrate worldwide, with main export markets spanning Asia, Africa, and the Middle East. Each exchange is supported by robust packaging-typically in vials-protecting the product from light and temperature variations. The packaging conforms to international standards, ensuring the concentrate remains effective upon arrival. Delivery times depend on destination and shipping agreements, usually ranging from a few days up to two weeks. Reliable handling guarantees the safe management of this elite pharmaceutical solution.

FAQ's of Docetaxel Injection Concentrate:

Q: How should Docetaxel Injection Concentrate be stored to preserve its efficacy?

A: Docetaxel Injection Concentrate must be stored in a refrigerator at 2-8C and protected from light to maintain its stability and ravishing purity.

Q: What cancers can Docetaxel Injection Concentrate treat?

A: This concentrate is primarily used in the chemotherapy treatment of breast cancer, lung cancer, and prostate cancer, making it a select choice for elite oncology care.

Q: When can I expect my order for Docetaxel Injection Concentrate to arrive?

A: Delivery time varies depending on destination, but most shipments reach their destination within several days to two weeks after order confirmation.

Q: Where is Docetaxel Injection Concentrate mainly exported from?

A: This pharmaceutical-grade concentrate is exported, manufactured, and supplied from India, reaching markets globally, especially across Asia, Africa, and the Middle East.

Q: What is the process for exchanging or returning the product if an issue arises?

A: Should an issue occur, contact the supplier immediately to discuss the exchange process. Returns and exchanges are handled according to specific agreements and packaging integrity guidelines.

Tell us about your requirement